Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 4 | 312.50 | 138.79 | 360.00 | 301.50 | 1.1940 | 1.3434 |
| BT-20 | PLX-4720 | 0.1 | uM | 4 | 312.50 | 138.79 | 402.00 | 301.50 | 1.3333 | 1.5862 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 312.50 | 138.79 | 298.00 | 301.50 | 0.9884 | 0.9792 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 4 | 312.50 | 138.79 | 330.00 | 301.50 | 1.0945 | 1.1681 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 408.00 | 301.50 | 1.3532 | 1.6206 | |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 312.50 | 138.79 | 296.00 | 301.50 | 0.9818 | 0.9674 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 343.00 | 301.50 | 1.1376 | 1.2442 | |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 312.50 | 138.79 | 312.00 | 301.50 | 1.0348 | 1.0621 |
| BT-20 | Etoposide | 0.01 | uM | 4 | 312.50 | 138.79 | 456.00 | 301.50 | 1.5124 | 1.8944 |
| BT-20 | Etoposide | 1 | uM | 4 | 312.50 | 138.79 | 228.00 | 301.50 | 0.7562 | 0.5581 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 312.50 | 138.79 | 374.00 | 301.50 | 1.2405 | 1.4246 |
| BT-20 | Etoposide | 10 | uM | 4 | 312.50 | 138.79 | 112.00 | 301.50 | 0.3715 | -0.1744 |
| BT-20 | Nilotinib | 0.0033113 | uM | 4 | 312.50 | 138.79 | 323.00 | 301.50 | 1.0713 | 1.1270 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 312.50 | 138.79 | 331.00 | 301.50 | 1.0978 | 1.1740 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 261.00 | 301.50 | 0.8657 | 0.7582 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 205.00 | 301.50 | 0.6799 | 0.4169 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 520.00 | 818.25 | 0.6355 | 0.4802 | |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 604.00 | 818.25 | 0.7382 | 0.6349 | |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 625.00 | 288.04 | 170.00 | 818.25 | 0.2078 | -0.2954 |
| BT-20 | 0 | uM | 4 | 625.00 | 288.04 | 798.00 | 818.25 | 0.9753 | 0.9670 | |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 625.00 | 288.04 | 822.00 | 818.25 | 1.0046 | 1.0061 |
| BT-20 | PLX-4720 | 0.31623 | uM | 4 | 625.00 | 288.04 | 730.00 | 818.25 | 0.8922 | 0.8541 |
| BT-20 | Nilotinib | 10 | uM | 4 | 625.00 | 288.04 | 1150.00 | 818.25 | 1.4054 | 1.5070 |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 625.00 | 288.04 | 240.00 | 818.25 | 0.2933 | -0.1141 |
| BT-20 | NVP-TAE684 | 10 | uM | 4 | 625.00 | 288.04 | 164.00 | 818.25 | 0.2004 | -0.3120 |